SAN LEANDRO, Calif.--(BUSINESS WIRE)--BioClin Therapeutics, Inc., a privately-held clinical stage drug development company, today announced the appointment of Scott Myers as Chief Executive Officer, and Julie Eastland as Chief Financial Officer and Chief Business Officer. Mr. Myers will also continue in his role as company Chairman.
CDMO Almac, which recently expanded its analytical services operations at its headquarters in Northern Ireland, has added to those capabilities with the acquisition of a privately held drug testing and analytical services company.